
New England Journal of Medicine Article Highlights Obicetrapib, a New Cholesterol-Lowering Drug for High-Risk Heart Patients
Dr. Christie Ballantyne contributes to global study demonstrating the drug’s potential. A newly published international study, “Safety and Efficacy of...